Loss of matriptase suppression underlies Spint1 mutation-associated ichthyosis and postnatal lethality

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2015-2022

  Szabo, Roman ^a   Kosa, Peter ^a   List, Karin ^b   Bugge, Thomas H ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1; MATRIPTASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ACANTHOSIS; ANIMAL TISSUE; ARTICLE; ENZYME REPRESSION; EPIDERMIS; FEMALE; FORESTOMACH; GENE; GENE MUTATION; GROWTH RETARDATION; HYPERKERATOSIS; HYPOTRICHOSIS; ICHTHYOSIS; MALE; MOUSE; NONHUMAN; PERINATAL DEATH; PRIORITY JOURNAL; SPINT1 GENE;

EID: 67049144594     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090053     Document Type: Article

References (46)

1. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C: Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 2003, 4:544-558 (Pubitemid 36781345)
2. Rawlings ND, Barrett AJ: Families of serine peptidases. Methods Enzymol 1994, 244:19-61
3. Rau JC, Beaulieu LM, Huntington JA, Church FC: Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007, 5 Suppl 1:102-115 (Pubitemid 46958823)
4. Marlor CW, Delaria KA, Davis G, Muller DK, Greve JM, Tamburini PP: Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains. J Biol Chem 1997, 272:12202-12208 (Pubitemid 27202805)
5. Itoh H, Kataoka H, Hamasuna R, Kitamura N, Koono M: Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human. Biochem Biophys Res Commun 1999, 255:740-748 (Pubitemid 29294869)
6. Muller-Pillasch F, Wallrapp C, Bartels K, Varga G, Friess H, Buchler M, Adler G, Gress TM: Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer. Biochim Biophys Acta 1998, 1395:88-95 (Pubitemid 28035524)
7. Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K, Kitamura N: Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 1997, 272:27558-27564 (Pubitemid 27473546)
8. Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, Kagaya S, Qin L, Takata H, Miyazawa K, Kitamura N: Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 1997, 272:6370-6376 (Pubitemid 27118113)
9. Oberst MD, Johnson MD, Dickson RB, Lin CY, Singh B, Stewart M, Williams A, al-Nafussi A, Smyth JF, Gabra H, Sellar GC: Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res 2002, 8:1101-1107 (Pubitemid 35177362)
10. Szabo R, Hobson JP, List K, Molinolo A, Lin CY, Bugge TH: Potent inhibition and global co-localization implicate the transmembrane kunitz-type serine protease inhibitor hai-2 in the regulation of epithelial matriptase activity. J Biol Chem 2008, 283:29495-29504
11. Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY: Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol 2001, 158:1301-1311 (Pubitemid 32281294)
12. Kataoka H, Suganuma T, Shimomura T, Itoh H, Kitamura N, Nabeshima K, Koono M: Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem 1999, 47:673-682 (Pubitemid 29237303)
13. Szabo R, Molinolo A, List K, Bugge TH: Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 2007, 26:1546-1556 (Pubitemid 46398747)
14. Denda K, Shimomura T, Kawaguchi T, Miyazawa K, Kitamura N: Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem 2002, 277:14053-14059 (Pubitemid 34968015)
15. Kirchhofer D, Peek M, Lipari MT, Billeci K, Fan B, Moran P: Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett 2005, 579:1945-1950 (Pubitemid 40404036)
16. Kirchhofer D, Peek M, Li W, Stamos J, Eigenbrot C, Kadkhodayan S, Elliott JM, Corpuz RT, Lazarus RA, Moran P: Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem 2003, 278:36341-36349 (Pubitemid 37139961)
17. Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N, Meininger D, Hoey T, Austin RJ: Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 2005, 390:125-136 (Pubitemid 41192238)
18. Delaria KA, Muller DK, Marlor CW, Brown JE, Das RC, Roczniak SO, Tamburini PP: Characterization of placental bikunin, a novel human serine protease inhibitor. J Biol Chem 1997, 272:12209-12214 (Pubitemid 27202806)
19. Fan B, Wu TD, Li W, Kirchhofer D: Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J Biol Chem 2005, 280:34513-34520 (Pubitemid 41504581)
20. Qin L, Denda K, Shimomura T, Kawaguchi T, Kitamura N: Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. FEBS Lett 1998, 436:111-114 (Pubitemid 28454616)
21. Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, Fukushima T, Miyata S, Uchiyama S, Uchinokura S, Shimomura T, Miyazawa K, Kitamura N, Yamada G, Kataoka H: Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 2005, 25:5687-5698 (Pubitemid 40853602)
22. Fan B, Brennan J, Grant D, Peale F, Rangell L, Kirchhofer D: Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Dev Biol 2007, 303:222-230 (Pubitemid 46241099)
23. Nagaike K, Kawaguchi M, Takeda N, Fukoshima T, Sawaguchi A, Kohama K, Setoyama M, Kataoka H: Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibior. Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice. Am J Pathol 2008, 173:1-12
24. Kim DR, Sharmin S, Inoue M, Kido H: Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung. Biochim Biophys Acta 2001, 1518:204-209 (Pubitemid 32232298)
25. Lin CY, Anders J, Johnson M, Sang QA, Dickson RB: Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 1999, 274:18231-18236 (Pubitemid 129519220)
26. Takeuchi T, Shuman MA, Craik CS: Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 1999, 96:11054-11061 (Pubitemid 29487326)
27. Tanimoto H, Underwood LJ, Wang Y, Shigemasa K, Parmley TH, O'Brien TJ: Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention. Tumour Biol 2001, 22:104-114
28. Szabo R, Bugge TH: Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 2008, 40:1297-1316
29. Hooper JD, Clements JA, Quigley JP, Antalis TM: Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 2001, 276:857-860 (Pubitemid 32096501)
30. Szabo R, Wu Q, Dickson RB, Netzel-Arnett S, Antalis TM, Bugge TH: Type II transmembrane serine proteases. Thromb Haemost 2003, 90:185-193 (Pubitemid 36992495)
31. List K, Hobson JP, Molinolo A, Bugge TH: Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase. J Cell Physiol 2007, 213:237-245 (Pubitemid 47378812)
32. Tursen U, Kaya TI, Ikizoglu G, Aktekin M, Aras N: Genetic syndrome with ichthyosis: congenital ichthyosis, follicular atrophoderma, hypotrichosis, and woolly hair; second report. Br J Dermatol 2002, 147:604-606 (Pubitemid 35015306)
33. Lestringant GG, Kuster W, Frossard PM, Happle R: Congenital ichthyosis, follicular atrophoderma, hypotrichosis, and hypohidrosis: a new genodermatosis? Am J Med Genet 1998, 75:186-189
34. Alef T, Torres S, Hausser I, Metze D, Tursen U, Lestringant GG, Hennies HC: Ichthyosis, follicular atrophoderma, and hypotrichosis caused by mutations in ST14 is associated with impaired profilaggrin processing. J Invest Dermatol 2008, 129:862-869
35. Avrahami L, Maas S, Pasmanik-Chor M, Rainshtein L, Magal N, Smitt J, van Marle J, Shohat M, Basel-Vanagaite L: Autosomal recessive ichthyosis with hypotrichosis syndrome: further delineation of the phenotype. Clin Genet 2008, 74:47-53 (Pubitemid 351833818)
36. Basel-Vanagaite L, Attia R, Ishida-Yamamoto A, Rainshtein L, Ben Amitai D, Lurie R, Pasmanik-Chor M, Indelman M, Zvulunov A, Saban S, Magal N, Sprecher E, Shohat M: Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14. encoding type II transmembrane serine protease matriptase. Am J Hum Genet 2007, 80:467-477 (Pubitemid 46310978)
37. List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W, Engelholm LH, Behrendt N, Bugge TH: Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 2002, 21:3765-3779 (Pubitemid 34620539)
38. List K, Szabo R, Wertz PW, Segre J, Haudenschild CC, Kim SY, Bugge TH: Loss of proteolytically processed filaggrin caused by epidermal deletion of matriptase/MT-SP1. J Cell Biol 2003, 163:901-910 (Pubitemid 37517896)
39. List K, Currie B, Scharschmidt TC, Szabo R, Shireman J, Molinolo A, Cravatt BF, Segre J, Bugge TH: Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice. J Biol Chem 2007, 282:36714-36723
40. List K, Szabo R, Molinolo A, Nielsen BS, Bugge TH: Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am J Pathol 2006, 168:1513-1525
41. Lee SL, Dickson RB, Lin CY: Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 2000, 275:36720-36725 (Pubitemid 32002078)
42. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS: Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 2000, 275:26333-26342 (Pubitemid 30676685)
43. Netzel-Arnett S, Currie BM, Szabo R, Lin CY, Chen LM, Chai KX, Antalis TM, Bugge TH, List K: Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem 2006, 281:32941-32945 (Pubitemid 46036678)
44. Kilpatrick LM, Harris RL, Owen KA, Bass R, Ghorayeb C, Bar-Or A, Ellis V: Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 2006, 108:2616-2623 (Pubitemid 44776996)
45. Lin CY, Anders J, Johnson M, Dickson RB: Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 1999, 274:18237-18242 (Pubitemid 129519221)
46. Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, Lee MS, Wang JK, Sloane DE, Johnson M, Lin CY: Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am J Physiol Cell Physiol 2008, 295:C423-C431 (Pubitemid 352755786)